生命科学资讯

Pfizer-backed Priovant scores again with fast-rising brepocitinib in midstage study

Chutes & Ladders—Moderna CMO steps down in leadership mix-up

Qiagen 'open for discussion' on shareholder value, but CEO stays mum on takeover talk

Medtronic hit with $382M antitrust ruling over surgical device monopoly

How Is The Market Feeling About Thermo Fisher Scientific Inc? - Benzinga

UniQure pauses higher doses in Fabry study; Aro shares Pompe data

ALTx formed to drug pathway by which cancer cells become immortal

Will Thermo Fisher Scientific (TMO) Benefit from Favorable Trends in the Market? - Yahoo Finance

Illumina, Inc. (NASDAQ:ILMN) Q4 2025 Earnings Call Transcript - Insider Monkey

What's Driving the Market Sentiment Around Agilent Technologies Inc? - Benzinga

Bayer sets the stage for a pharma comeback

O-GlcNAcase inhibitors reported in Tyk Medicines patent

Abbisko Therapeutics identifies GTPase KRAS mutant inhibitors

Shenzhen Salubris Pharmaceuticals synthesizes dual PCSK9/HMG-CoA reductase inhibitors

Agomab, SpyGlass head to Nasdaq with IPOs totaling $350M

NICE greenlights Abbott's cardiac sensor implant for NHS

Geoff McDonough's big plans for NodThera's NLRP3; Enhertu leader steps down at Daiichi

Roivant spinout Priovant touts Phase 2 brepocitinib data in cutaneous sarcoidosis

Post-Hoc Live: Analyzing the Novo vs. Hims GLP-1 showdown

Linscomb Wealth Inc. Invests $2.94 Million in Agilent Technologies, Inc. $A - MarketBeat